Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
ViSync® Technologies, a joint venture between Hovione and iBET is proud to announce the appointment of Elsa Abranches as its Chief Scientific Officer (CSO).
Irish Examiner, 25 November 2024
EchoLive, 25 November 2024
Hovione has completed significant expansions at its facilities in New Jersey, USA, and Cork, Ireland.
Excipient and delivery device selection play crucial roles in the formulation of inhaled drugs.
A partnership to accelerate the development of the Dispersome® technology platform and further expand its applicability and reach for increasing the solubility and bioavailability of small drug molecules.
Commitment to partnership and joint innovation for cell and gene therapies
Hovione commitment to setting SBTs in line with the Paris Agreement
Hovione proudly announces its collaborative venture with Higuchi.
Hovione is proud to announce the opening of a state-of-the-art continuous tableting (CT) line at its R&D Center in Lisbon.
Google Chrome
Safari
Firefox
Edge